Anti-tumor Immunotherapy via Antigen Delivery from a Live Attenuated Genetically Engineered Pseudomonas aeruginosa Type III Secretion System-Based Vector-Reference-Cited by-同舟云学术

Anti-tumor Immunotherapy via Antigen Delivery from a Live Attenuated Genetically Engineered Pseudomonas aeruginosa Type III Secretion System-Based Vector

Published:2006-11 Issue:5 Volume:14 Page:656-661
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Epaulard Olivier,Toussaint Bertrand,Quenee Lauriane,Derouazi Madiha,Bosco Nabil,Villiers Christian,Le Berre Rozenn,Guery Benoit,Filopon Didier,Crombez Laurence,Marche Patrice N.,Polack Benoit

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference22 articles.

1. Progress on new vaccine strategies for the immunotherapy and prevention of cancer;Berzofsky;J. Clin. Invest.,2004

2. Live bacteria as the basis for immunotherapies against cancer;Chabalgoity;Expert Rev. Vaccines,2002

3. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy;Radford;Gene Ther.,2002

4. Delivery of epitopes by the Salmonella type III secretion system for vaccine development;Russmann;Science,1998

5. Protein delivery by Pseudomonas type III secretion system: ex vivo complementation of p67(phox)-deficient chronic granulomatous disease;Polack;Biochem. Biophys. Res. Commun.,2000

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered bacteria in tumor immunotherapy;Cancer Letters;2024-05

2. Current advances in bacteria‐based cancer immunotherapy;European Journal of Immunology;2023-12-17

3. Therapeutic potential of Pseudomonas aeruginosa-mannose sensitive hemagglutinin (PA-MSHA) in cancer treatment;Microbial Pathogenesis;2023-12

4. Bacteria-driven cancer therapy: Exploring advancements and challenges;Critical Reviews in Oncology/Hematology;2023-11

5. Current advances in microbial-based cancer therapies;Medical Oncology;2023-06-18